$239,61
-$1,36(-%0,56)
*Data last updated: 2026-04-07 18:24 (UTC+8)
As of 2026-04-07 18:24, Johnson & Johnson (JNJ) is priced at $239,61, with a total market cap of $575,84B, a P/E ratio of 18,80, and a dividend yield of %2,17. Today, the stock price fluctuated between $236,12 and $240,78. The current price is %1,47 above the day's low and %0,48 below the day's high, with a trading volume of 1,57M. Over the past 52 weeks, JNJ has traded between $146,11 to $251,71, and the current price is -%4,80 away from the 52-week high.
JNJ Key Stats
Yesterday's Close$240,97
Market Cap$575,84B
Volume1,57M
P/E Ratio18,80
Dividend Yield (TTM)%2,17
Dividend Amount$1,30
Diluted EPS (TTM)11,03
Net Income (FY)$26,80B
Revenue (FY)$94,19B
Earnings Date2026-04-14
EPS Estimate2,69
Revenue Estimate$23,60B
Shares Outstanding2,38B
Beta (1Y)0.329
Ex-Dividend Date2026-02-24
Dividend Payment Date2026-03-10
About JNJ
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
SectorHealthcare
IndustryDrug Manufacturers - General
CEOJoaquin Duato
HeadquartersNew Brunswick,NJ,US
Official Websitehttps://www.jnj.com
Employees (FY)138,20K
Average Revenue (1Y)$681,57K
Net Income per Employee$193,95K
Johnson & Johnson (JNJ) FAQ
What's the stock price of Johnson & Johnson (JNJ) today?
x
Johnson & Johnson (JNJ) is currently trading at $239,61, with a 24h change of -%0,56. The 52-week trading range is $146,11–$251,71.
What are the 52-week high and low prices for Johnson & Johnson (JNJ)?
x
What is the price-to-earnings (P/E) ratio of Johnson & Johnson (JNJ)? What does it indicate?
x
What is the market cap of Johnson & Johnson (JNJ)?
x
What is the most recent quarterly earnings per share (EPS) for Johnson & Johnson (JNJ)?
x
Should you buy or sell Johnson & Johnson (JNJ) now?
x
What factors can affect the stock price of Johnson & Johnson (JNJ)?
x
How to buy Johnson & Johnson (JNJ) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
